Can-Fite BioPharma American Depositary Shares
CANF
2 hedge funds and large institutions have $1.22M invested in Can-Fite BioPharma American Depositary Shares in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
49% less capital invested
Capital invested by funds: $2.39M → $1.22M (-$1.18M)
60% less funds holding
Funds holding: 5 → 2 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$314K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$249K |
| 3 |
Morgan Stanley
New York
|
-$80K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$8K |
| 5 |
Citigroup
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $795K | -$314K | -23 | -24% |
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $417K | – | – | – |
|
|
BRWA
3
B. Riley Wealth Advisors
Boca Raton,
Florida
| $3.57K | – | – | – |
|
|
4
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$249K | -16 | Closed |
|
|
5
Morgan Stanley
New York
| – | -$80K | -5 | Closed |
|
|
U
6
UBS
Zurich,
Switzerland
| – | -$8K | -1 | Closed |
|
|
7
Citigroup
New York
| – | -$2K | – | – |
|
CANF Hedge Fund Activity: Q2 2014 in Review
2 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q2 2014, worth a combined $1.22M — down 49% from $2.39M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CANF and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, cutting an estimated $314K.
- 2 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q2 2014, down from 5 in Q1 2014.
- Funds reported $1.22M of Can-Fite BioPharma American Depositary Shares stock for Q2 2014, down 49% quarter-over-quarter.
- 0 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q2 2014 and 3 closed out, a net change of -3 holders.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q2 2014 was Susquehanna International Group, an estimated $314K sold.
Based on aggregated 13F filings for Q2 2014.